학술논문
Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients
Document Type
Article
Author
Source
American Journal of Kidney Diseases; September 2022, Vol. 80 Issue: 3 p309-318, 10p
Subject
Language
ISSN
02726386; 15236838
Abstract
High-dose influenza vaccine provides better protection against influenza infection in older adults than standard-dose vaccine. We compared vaccine seroresponse among hemodialysis patients over a period of 4 months after administration of high-dose trivalent inactivated (HD-IIV3), standard-dose quadrivalent inactivated (SD-IIV4), or quadrivalent recombinant quadrivalent (RIV4) influenza vaccine.